Previous Close | 66.52 |
Open | 66.63 |
Bid | 66.08 x 1000 |
Ask | 66.12 x 1100 |
Day's Range | 65.50 - 67.00 |
52 Week Range | 52.60 - 84.23 |
Volume | |
Avg. Volume | 638,527 |
Market Cap | 6.719B |
Beta (5Y Monthly) | 1.15 |
PE Ratio (TTM) | 36.44 |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
AUDUBON, Pa., Aug. 04, 2022 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced its financial results for the quarter ended June 30, 2022. Worldwide net sales were $263.6 million, an increase of 5.0% as reported, and an increase of 6.5% on a constant currency basis, compared to the second quarter of 2021GAAP net income for the quarter was $54.6 millionGAAP diluted earnings per share (“EPS”) was $0.53 and non-GAAP diluted EPS was $0.
ExcelsiusGPS® Advances Robotic Navigation Spine SurgeryWESTMEAD, Australia, July 28, 2022 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, announced today the first spinal surgeries with ExcelsiusGPS® in Sydney were performed at Westmead Private Hospital. ExcelsiusGPS®, the world’s first revolutionary robotic navigation platform, is designed to improve safety and accuracy in the operating room. Dr. Jun Kim at Westmead Private Hospital performed
AUDUBON, Pa., July 18, 2022 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its financial results for the second quarter ended June 30, 2022 after the market close on Thursday, August 4, 2022. A copy of the release will be available on the Globus Medical website at www.investors.globusmedical.com. Following the announcement, Globus Medical will hold a teleconference to discuss its performance with the investment community at 4:30 p